Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand
Barbara Łasut-Szyszka(The Maria Sklodowska-Curie National Research Institute of Oncology), Marek Rusin(National Institute of Oncology)
Cited by 8
Related Papers
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
|British Journal of Cancer|2015|52
Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol
|Molecular Biology Reports|2013|13
Strong Activation of p53 by Actinomycin D and Nutlin-3a Overcomes Resistance of Cancer Cells to the Pro-apoptotic Activity of FAS Ligand
|Preprints.org|2023|2
Puzzling Regulation of Interferon Signaling System by p53 Tumor Suppressor Protein
|Preprints.org|2024|1